U.S. hedge fund, Elliott Associates, has objected to DuPont’s $5.8 billion offer for Danisco, Financial Times reports. Elliott, who has a 1.2% stake in the Danish pharmaceutical company, has written to its directors opposing the deal. SEB Asset Management of Sweden, which owns about 2%